He cautioned that the study, known as BRIDGE, “does not apply to patients with prosthetic heart valves or patients with venous thromboembolism, like a deep vein thrombosis or pulmonary embolism. But for patients with atrial fibrillation, it’s high-quality data that should indicate that people do not need to use anything to bridge these folks.”
The National Heart, Lung, and Blood Institute funded this research. Ten coauthors reported relationships with pharmaceutical companies.
—Reuters Health
Drr. Taylor Clinical question: Does Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) use lead to an increased risk of aspiration in patients undergoing anesthesia for elective...
Clinical question: In patients on antihypertensive medications (AHMs) such as angiotensin-converting-enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) undergoing inpatient...
Dr. Fadden Clinical question: Which is a better approach for patients with chronic limb-threatening ischemia (CLTI): surgery or endovascular therapy? Background: CLTI is a complication of...
What is the sum of evidence supporting perioperative cardiac risk assessment and risk reduction?
